Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.20609 | 49 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.39436 | 56 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.17408 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.08795 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.33776 | 55 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.293 | 50 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.2089 | 48 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.14005 | 48 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.10136 | 47 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.12934 | 48 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.16501 | 49 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.09484 | 48 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.12687 | 47 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.16184 | 49 |